LVV SMRTcap reveals extensive proviral variation in lentiviral vector-transduced CAR T cells
Molecular Therapy Advances · 2026-12 · 34 (4) · 201863
DOI: 10.1016/j.omta.2026.201863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-12. Verfasst von Catherine W Kaiser und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40202, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Lentiviral vectors are commonly used to introduce chimeric antigen receptor transgenes into T cells, but routine assays quantify vector copy number or integration sites without sequencing full-length integrated vectors. HIV-1 proviruses often acquire large deletions and cytidine deaminase-driven hypermutation; whether similar variation occurs in therapeutic lentiviral vectors is unclear. We adapted an innovative long-read capture approach to enrich long fragments spanning vector DNA and adjacent human sequence, enabling simultaneous integration-site mapping and proviral integrity analysis with single-molecule resolution. In research-grade CAR T cells produced with an experimental, transient-transfection lentiviral vector workflow, 40% of integrated vectors carried recurrent deletions that removed the internal promoter or parts of the chimeric antigen receptor cassette. The dominant promoter deletion was present in the viral stock. In clinical chimeric antigen receptor T cell products, promoter deletions were less frequent, but detectable pre-infusion and post-infusion. Across datasets, we observed widespread G-to-A substitutions consistent with restriction factor editing, including changes predicted to introduce premature stop codons within the transgene open reading frame. Our method reveals proviral variants invisible to standard quality-control assays and provides a framework to improve vector production and monitor transgene integrity in clinical products.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40202, USA.
- Department of Pediatrics Division of Hematology, Oncology and Stem Cell Transplantation, University of Louisville School of Medicine, Louisville, KY 40202, USA.
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health Office of the Director
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Kaiser, C. W., Elliott, E. M., Mehs, G. S., Mroczkowska, J. E., Murray, C. S., Jain, A., Ferguson, M., Garfall, A. L., Bushman, F. D., Fraietta, J. A., Rouchka, E. C., & Smith, M. L. (2026). LVV SMRTcap reveals extensive proviral variation in lentiviral vector-transduced CAR T cells. Molecular Therapy Advances, 34(4), 201863. https://doi.org/10.1016/j.omta.2026.201863
Vancouver
Kaiser CW, Elliott EM, Mehs GS, Mroczkowska JE, Murray CS, Jain A, et al. LVV SMRTcap reveals extensive proviral variation in lentiviral vector-transduced CAR T cells. Molecular Therapy Advances. 2026;34(4):201863. doi:10.1016/j.omta.2026.201863
BibTeX
@article{Kaiser2026,
author = {Kaiser, Catherine W and Elliott, Erin M and Mehs, Ghazal S and Mroczkowska, Joanna E and Murray, Connor S and Jain, Ankita and Ferguson, Michael and Garfall, Alfred L and Bushman, Frederic D and Fraietta, Joseph A and Rouchka, Eric C and Smith, Melissa L},
title = {LVV SMRTcap reveals extensive proviral variation in lentiviral vector-transduced CAR T cells},
journal = {Molecular Therapy Advances},
year = {2026},
volume = {34},
number = {4},
pages = {201863},
doi = {10.1016/j.omta.2026.201863}
}
EUVIMED